Richard Burr: “As Ranking Member, I do have some responsibilities to Members on this side of the aisle to actively do oversight.”

Nobody has worked harder on this issue, I think, on the Hill than I have.

I oppose Ms. Kotagal's nomination and urge my colleagues to do the same.

It is not for some, it is for all.

It is time that we hold the FDA accountable.